THANK YOU FOR SUBSCRIBING
When healthcare buyers talk about buying AI-powered care continuity solutions, it gets complicated. They are not just looking at how the software can automate things or make workflows better. They have to think about how the technology helps with coordination for patients over a long time.
This is changing how they decide what to buy. In the past, they just looked at how hard it was to set up the software, how well it worked with systems and if people would use it. Care continuity platforms are different because they need to work well even when patients are not in the hospital or clinic.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Many healthcare organizations have places where patients get care. Patients may see doctors, get help from different services and go to different care settings. Care continuity platforms are supposed to help with these transitions. Buyers have to figure out if the technology will work well with their specific way of referring patients and talking to each other.
The problem is that it is hard to measure if care continuity is working. You can look at how appointments a scheduling system handles or how fast documentation software works. Care continuity is about what happens over a long time, and it depends on many things that the technology company cannot control.
This is making buyers more careful. They are looking closely at what they need to do to make the technology work and how it will affect their workflows. They want to know how the technology will help with outreach, how care teams will use the recommendations, and who will be responsible when follow-up activities are needed.
Another thing that is important is whether the organization is ready. AI can suggest which patients need help. The healthcare provider needs to have enough staff to respond. A continuity platform can show when appointments are missed or referrals are delayed. That information is not useful if the process of reaching out to patients is not working well.
The people talking about buying the technology are coming from various areas. Technology leaders, doctors and care management teams have ideas about what is important. One group might care about how the technology works with other systems, while another group cares about how patients will use it.
It is just as important to make sure everyone agrees as it is to look at how the software works. Companies that sell these platforms are finding that buyers are not asking many questions about how smart the AI is. Instead, they are asking about how it will work in life.
This matters because the challenges with care continuity often happen because of mistakes when patients are moved from one care team to another. Because of delays in communication or because it is not clear who is responsible.
AI-powered care continuity platforms are in a place in the healthcare technology market. They promise to help us see what is happening with patients. They will only work if the organization is ready to use the information.
For healthcare buyers, the big question is not whether AI can find gaps in care continuity. The harder question is whether their teams, workflows and management are ready to do something, about what the technology shows them. Healthcare buyers have to think about AI care continuity platforms and how they will work in their organizations. They have to consider how the technology will help with coordination and care continuity.
AI care continuity platforms are changing how healthcare buyers evaluate technology.
More in News